Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Da Prada

Showing results (91-100 of 175) with videos related to

Pageof 18
Sort By:
Modern Problems of Pharmacopsychiatry|January 1, 1983
Neurochemical effects in vitro and in vivo of the antidepressant Ro 11-1163, a specific and short-acting MAO-A inhibitorM Da Prada, R Kettler, H H Keller, et al.
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio|December 1, 1984
[Levels of free and conjugated catecholamines in amniotic fluid and in umbilical and maternal blood in patients undergoing cesarean section]N Bardazzi, P Ciolini, A Donzella, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1973
The effect of 5,6-dihydroxytryptamine on uptake, storage and metabolism of 5-hydroxytryptamine by blood plateletsM Da Prada, R A O'Brien, J P Tranzer, et al.
Journal of Neurochemistry|May 1, 1992
Expression of functional membrane-bound and soluble catechol-O-methyltransferase in Escherichia coli and a mammalian cell lineP Malherbe, B Bertocci, P Caspers, et al.
The American Journal of Physiology|March 1, 1994
Estimation of rate constants for serotonin uptake and compartmentation in normal human plateletsG Launay, J L Costa, M Da Prada, et al.
The Journal of Pharmacy and Pharmacology|December 1, 1975
Cerebral monoamine metabolism in guinea-pigs with ascorbic acid deficiencyA Saner, H Weiser, D Hornig, et al.
Pharmacopsychiatry|March 1, 1985
Serotonin involvement in lisuride-induced mounting and in sleepM Da Prada, E P Bonetti, R Scherschlicht, et al.
Journal of Neurochemistry|January 1, 1987
Binding of [3H]Ro 16-6491, a reversible inhibitor of monoamine oxidase type B, to human brain mitochondria and platelet membranesA M Cesura, M D Galva, R Imhof, et al.
Advances in Neurology|January 1, 1990
Ro 19-6327, a reversible and highly selective monoamine, oxidase B inhibitor: a novel tool to explore the MAO-B function in humansW E Haefely, R Kettler, H H Keller, et al.
Brain Research|August 9, 1974
Decrease of dopamine and 5-hydroxytryptamine after intracerebral application of 5,6-dihydroxytryptamineA Saner, L Pieri, J Moran, et al.
Pageof 18

Showing results (91-100 of 175) with videos related to

Sort By:
Pageof 18
Modern Problems of Pharmacopsychiatry|January 1, 1983
Neurochemical effects in vitro and in vivo of the antidepressant Ro 11-1163, a specific and short-acting MAO-A inhibitorM Da Prada, R Kettler, H H Keller, et al.
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio|December 1, 1984
[Levels of free and conjugated catecholamines in amniotic fluid and in umbilical and maternal blood in patients undergoing cesarean section]N Bardazzi, P Ciolini, A Donzella, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1973
The effect of 5,6-dihydroxytryptamine on uptake, storage and metabolism of 5-hydroxytryptamine by blood plateletsM Da Prada, R A O'Brien, J P Tranzer, et al.
Journal of Neurochemistry|May 1, 1992
Expression of functional membrane-bound and soluble catechol-O-methyltransferase in Escherichia coli and a mammalian cell lineP Malherbe, B Bertocci, P Caspers, et al.
The American Journal of Physiology|March 1, 1994
Estimation of rate constants for serotonin uptake and compartmentation in normal human plateletsG Launay, J L Costa, M Da Prada, et al.
The Journal of Pharmacy and Pharmacology|December 1, 1975
Cerebral monoamine metabolism in guinea-pigs with ascorbic acid deficiencyA Saner, H Weiser, D Hornig, et al.
Pharmacopsychiatry|March 1, 1985
Serotonin involvement in lisuride-induced mounting and in sleepM Da Prada, E P Bonetti, R Scherschlicht, et al.
Journal of Neurochemistry|January 1, 1987
Binding of [3H]Ro 16-6491, a reversible inhibitor of monoamine oxidase type B, to human brain mitochondria and platelet membranesA M Cesura, M D Galva, R Imhof, et al.
Advances in Neurology|January 1, 1990
Ro 19-6327, a reversible and highly selective monoamine, oxidase B inhibitor: a novel tool to explore the MAO-B function in humansW E Haefely, R Kettler, H H Keller, et al.
Brain Research|August 9, 1974
Decrease of dopamine and 5-hydroxytryptamine after intracerebral application of 5,6-dihydroxytryptamineA Saner, L Pieri, J Moran, et al.
Pageof 18